Interplay of Drug Metabolism and Transport: A Real Phenomenon or an Artifact of the Site of Measurement?
- 3 November 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 6 (6), 1756-1765
- https://doi.org/10.1021/mp9002392
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humansNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2008
- Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugsExpert Opinion on Drug Metabolism & Toxicology, 2008
- Coordinated induction of drug transporters and phase I and II metabolism in human liver slicesEuropean Journal of Pharmaceutical Sciences, 2008
- Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptakeXenobiotica, 2007
- Prediction of Intestinal First-Pass Drug MetabolismCurrent Drug Metabolism, 2007
- Valproic Acid Induces CYP3A4 and MDR1 Gene Expression by Activation of Constitutive Androstane Receptor and Pregnane X Receptor PathwaysDrug Metabolism and Disposition, 2007
- Effects of Uptake and Efflux Transporter Inhibition on Erythromycin Breath Test ResultsClinical Pharmacology & Therapeutics, 2007
- Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functionsPharmacology & Therapeutics, 2006
- MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotypeClinical Pharmacology & Therapeutics, 2006
- In Vivo Effects of Cyclosporin A and Ketoconazole on the Pharmacokinetics of Representative Substrates for P-Glycoprotein and Cytochrome P450 (CYP) 3A in RatsBiological & Pharmaceutical Bulletin, 2005